Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes

J Pharm Sci. 2005 Oct;94(10):2266-75. doi: 10.1002/jps.20443.

Abstract

Galactosylated (Gal) liposomes containing various molar ratios of cholesten-5-yloxy-N-(4-((1-imino-2-D-thiogalactosylethyl)formamide (Gal-C4-Chol) as a ligand for asialoglycoprotein receptors were prepared to study the effect of the galactose content of Gal-liposomes labeled with [3H]cholesteryl hexadecyl ether on their targeted delivery to hepatocytes. The uptake characteristics of Gal-liposomes having Gal-C4-Chol of 1.0%, 2.5%, 3.5%, 5.0%, and 7.5% were evaluated. The uptake and internalization by HepG2 cells was enhanced by the addition of Gal-C4-Chol to the Gal-liposomes. In the presence of excess galactose, the uptake of Gal-liposomes having Gal-C4-Chol of 3.5%, 5.0%, and 7.5% was inhibited suggesting asialoglycoprotein receptor mediated uptake. After intravenous injection, Gal-liposomes having Gal-C4-Chol of 3.5%, 5.0%, and 7.5%, rapidly disappeared from the blood and exhibited rapid liver accumulation with up to about 80% of the dose within 10 min whereas Gal-liposomes having low Gal-C4-Chol (1.0% and 2.5%) showed a slight improvement in liver accumulation compared with bare-liposomes. Gal-liposomes with high Gal-C4-Chol are preferentially taken up by hepatocytes and the highest uptake ratio by parenchymal cells (PC) and nonparenchymal cells (NPC) (PC/NPC ratio) was observed with Gal-liposomes having of 5.0% Gal-C4-Chol. We report here that the galactose density of Gal-liposomes prepared by Gal-C4-Chol is important for both effective recognition by asialoglycoprotein receptors and cell internalization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Area Under Curve
  • Asialoglycoprotein Receptor / drug effects
  • Asialoglycoprotein Receptor / metabolism*
  • Cell Line, Tumor
  • Cholestenes / chemistry
  • Drug Carriers*
  • Galactose / chemistry*
  • Galactose / pharmacology
  • Hepatocytes / metabolism
  • Humans
  • Liposomes / chemistry*
  • Liposomes / pharmacokinetics
  • Liver / metabolism
  • Male
  • Mice
  • Particle Size
  • Time Factors
  • Tissue Distribution
  • Tritium

Substances

  • Asialoglycoprotein Receptor
  • Cholestenes
  • Drug Carriers
  • Liposomes
  • cholesten-5-yloxy-N-(4-((1-imino-2-D-thiogalactosylethyl)amino)butyl)formamide
  • Tritium
  • Galactose